HGF gene — Drug Target
All drugs that target HGF gene — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- TissueGene-C · Kolon TissueGene, Inc. · Gene therapy · Liver disease
TissueGene-C is a gene therapy that uses a viral vector to deliver the human hepatocyte growth factor (HGF) gene to the liver, promoting tissue repair and regeneration.